BioNTech SE (BNTX) Misses Q2 EPS by 19c; reaffirms guidance

BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of (EUR1.60), EUR0.19 worse than the analyst estimate of (EUR1.41). Revenue for the quarter came in at EUR260.8 million versus the consensus estimate of EUR137.9 million.

GUIDANCE:

BioNTech SE sees FY2025 revenue of EUR1.7-2.2 billion, versus the consensus of EUR2.27 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• JPMorgan Reiterates Overweight Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)
• UBS Starts Diagnosticos da America SA (DASA3:BZ) at Buy
• JPMorgan Starts NexGen Energy Ltd. (NXE:CN) (NXE) at Overweight